Effects of cetrorelix, a GnRH-receptor antagonist, on gonadal axis in women with functional hypothalamic amenorrhea

Gynecological Endocrinology

Volumn 27, Issue 10, 2011, Pages 753-758

  Berardelli, Rita ^a   Gianotti, Laura ^b   Karamouzis, Ioannis ^a   Picu, Andreea ^a   Giordano, Roberta ^c   D'Angelo, Valentina ^a   Zinn, Domenico ^a   Lanfranco, Fabio ^a   Ghigo, Ezio ^a   Arvat, Emanuela ^a  

^a MOLINETTE HOSPITAL   (Italy)

^b S CROCE E CARLE HOSPITAL   (Italy)

^c UNIVERSITY OF TURIN   (Italy)

Author keywords

Cetrorelix; FSH; GnRH antagonists; hypothalamic amenorrhea; LH; oestradiol

Indexed keywords

CETRORELIX; ESTRADIOL; FOLLITROPIN; GONADOTROPIN; LUTEINIZING HORMONE;

ADULT; AMENORRHEA; ARTICLE; BODY MASS; CASE REPORT; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; FEMALE; FUNCTIONAL HYPOTHALAMIC AMENORRHEA; GONADOTROPIN RELEASE; HUMAN; HYPOPHYSIS GONAD SYSTEM; INJECTION SITE DISCOMFORT; PRIORITY JOURNAL;

ADULT; AMENORRHEA; ESTRADIOL; FEMALE; FOLLICLE STIMULATING HORMONE, HUMAN; GONADOTROPIN-RELEASING HORMONE; HORMONE ANTAGONISTS; HUMANS; HYPOTHALAMIC DISEASES; LUTEINIZING HORMONE; OVARY; PITUITARY GLAND; RECEPTORS, LHRH; TIME FACTORS;

EID: 79960838670     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513590.2010.526661     Document Type: Article

References (22)

1. Schally AV, Comaru-Schally AM, Nagy A, Kovacs M, Szepeshazi K, Plonowski A, Varga JL, Halmos G. Hypothalamic hormones and cancer. Front Neuroendocrinol 2001;22: 248-291
2. Reissmann T, Schally AV, Bouchard P, Riethmüller H, Hengel J. The LHRH antagonist cetrorelix: a review. Hum Reprod Update 2000;6:322-331
3. Huirne JAF, Lambalk CB. Gonadotrophin-releasing-hormone- receptor antagonists. Lancet 2001;358:1793-1803
4. Halmos G, Schally AW, Pinski J, Vadillo-Buenfil M, Groot K. Down-regulation of pituitary receptors for luteinizing hormone- releasing hormone (LHRH) in rats by LH-RH antagonist cetrorelix. Proc Natl Acad Sci USA 1996;93:2398-2402
5. Erb K, Klipping C, Duijkers I, Pechstein B, Achueler A, Hermann R. Pharmacodynamic effects and plasma pharmacokinetics of single doses of cetrorelix acetate in healthy premenopausal women. Fertil Steril 2001;75:316-323
6. Behre HM, Klein B, Steinmeyer E, McGregor G, Voigt K, Nieschlag E. Effective suppression of luteinizing hormone and testosterone by single doses of the new gonadotrophinreleasing hormone antagonist cetrorelix (SB-75) in normal men. J Clin Endocrinol Metab 1992;75:393-398
7. Engel JB, Shally AV. Drug insight: clinical use of agonists and antagonists of luteinizing-hormone-releasing hormone. Nat Clin Pract Endocrinol Metab 2007;3:157-167
8. Debruyne F, Bhat G, Garnick MB. Abarelix for injectable suspension: first-in-class gonadotropin-releasing hormone antagonist for prostate cancer. Future Oncol 2006;2:677-696
9. Han YG, Kang S, Seong JY, Geum D, Suh YH, Kim K. Negative regulation of gonadotrophin releasing hormone and gonadotrophin releasing hormone receptor gene expression by a gonadotrophin releasing homone agonist in the rat hypothalamus. J Endocrinol 1999;11:195-201
10. Li S, Pelletier G. Involvement of an autoregulatory mechanism for the regulation of gonadotrophin-releasing hormone (GnRH) gene expression in neurons in the rat preoptic area. Neurosci Lett 1994;174:61-63
11. Cho S, Han J, Sun W, Choi D, Bang Kwon H, Jarry H, Wuttke W, Kim K. Evidence for autocrine inhibition of gonadotrophin-releasing hormone (GnRH) gene transcription by GnRH in hypothalamic GT1-1 neuronal cells. Mol Brain Res 1997;50:51-58
12. Gianotti L, Veldhuis JD, Destefanis S, Lanfranco F, Ramunni J, Arvat E, Marzetto M, Boutignon F, Deghenghi R, Ghigo E. Suppression and recovery of LH secretion by a potent and selective GnRH-receptor antagonist peptide in healthy early follicular-phase women are mediated via selective control of LH secretory burst mass. Clin Endocrinol (Oxf) 2003;59:526-532
13. Pechstein B, Nagaraja NV, Hermann R, Romeis P, Locher M, Derendorf H. Pharmacokinetic-pharmacodynamic modeling of testosterone and luteinizing hormone suppression by cetrorelix in healthy volunteers. J Clin Pharmacol 2000;40: 266-274
14. Gonzalez-Barcena D, Vadillo-Buenfil M, Garcia-Procel E. Inhibition of luteinizing hormone, follicle-stimulating hormone and sex-steroid levels in men and women with a potent antagonist analog of luteinizing hormone-releasing hormone, cetrorelix (SB-75). Eur J Endocrinol 1994;131:286-292
15. Sommer L, Zanger K, Dyiong T, Luckhaus J, Diedrich K, Klingmuller D. Seven-day administration of the gonadotropin- releasing hormone antagonist cetrorelix in normal cycling women. Eur J Endocrinol 1994;131:280-285
16. Tsutsumi R, Webster NJ. GnRH pulsatility, the pituitary response and reproductive dysfunction. Endocr J 2009;56: 729-737
17. Genazzani AD, Ricchieri F, Lanzoni C, Strucchi C, Jasonni VM. Diagnostic and therapeutic approach to hypothalamic amenorrea. Ann N Y Acad Sci 2006;1092:103-113
18. Berga SH, Loucks TM. Use of cognitive behaviour therapy for functional hypothalamic amenorrhea. Ann N Y Acad Sci 2006;1092:114-129
19. Letterie GS, Coddington CC, Collins RL, Merriam GR. Ovulation induction using s.c. pulsatile gonadotropin releasing- hormone: effectiveness of different pulse frequencies. Hum Reprod 1996;11:19-22
20. Perkins RB, Hall JE, Martin KA. Neuroendocrine abnormalities in Hypothalamic amenorrhea: spectrum, stability, and response to neurotransmitter modulation. J Clin Endocrinol Metab 1999;84:1905-1911
21. Miller KK, Parulekar MS, Schoenfeld E, Anderson E, Hubbard J, Klibanski A, Grinspoon SK. Decreased leptin levels in normal weight women and women with hypothalamic amenorrhea: the effects of body composition and nutritional intake. J Clin Endocrinol Metab 1998;83:2309-2312
22. Chan JL, Mantzoros CS. Role of leptin in energy-deprivation states: normal human physiology and clinical implications for hypothalamic amenorrhea and anorexia nervosa. Lancet 2005;366:74